Screening for breast cancer with mammography
44 results
1 - 44
Screening for breast cancer with mammography 
Screening for breast cancer with mammography: Cochrane systematic review- Mammography in combination with breast ultrasonography versus mammography for breast cancer screening in women at average risk: Cochrane systematic review
Adding ultrasound to mammography increases false-positive findings without an increase in cancer detection- Breast cancer screening benefits overrated
- Switching to digital mammography for all is too costly
- Breast cancer screening with MRI: more false-positives, more biopsies
- Population screening for cancer
- Mammography doesn't decrease cancer-related deaths long-term
- USPSTF: No routine mammography for women younger than 50 years
- Interventions for relieving the pain and discomfort of screening mammography: Cochrane systematic review
- Mammography identifies many women who will not benefit from treatment
- Combined ultrasound + mammogram for high-risk women increases cancer yield
- Screening mammography overdiagnoses women with breast cancer
- European guidelines on breast cancer screening 2020
- Guideline: Mammography optional in women 40-49
- Annual mammography starting at 40 doesn't lower breast CA mortality
- Small benefit to breast cancer screening for most women
- Numbers to help women understand the benefits/ harms of screening mammography
- Breast cancer
- Overuse alert: Computer aid does not improve mammography accuracy
- Overdiagnosis of breast cancer is common
- Strategies for increasing the participation of women in community breast cancer screening: Cochrane systematic review
- Clinical breast examination: lump, pain and benign changes
- Screening for breast cancer: False-positive rates 60% over 10 years
- Supplemental MRI screening in women with very dense breasts reduces interval cancer rate but may cause overdiagnosis (DENSE)
- American College of Physicians: mammography every 2 years between the ages 50 and 74 years
- No change in mammography rates after 2009 USPSTF update
- Mobile clinics for women's and children's health: Cochrane systematic review
- Follow-up strategies for women treated for early breast cancer: Cochrane systematic review
- Postoperative tamoxifen for ductal carcinoma in situ New
- Post-operative radiotherapy for ductal carcinoma in situ of the breast: Cochrane systematic review
- Limited evidence of benefit to treating low-grade DCIS
- Prostate cancer